Clinical Trial

A Trial of HRS-7085 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The study is being conducted to evaluate the safety, tolerability and pharmakokinetics of HRS-7085 in adults.
Trial Details
NCT Number NCT07760831
Lead Sponsor Jiangsu HengRui Medicine Co., Ltd.
Conditions Moderate to Severe Ulcerative Colitis
Enrollment 8 participants
Start Date 2026-08
Primary Completion 2027-04 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-12